These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 34494070)

  • 21. Attitudes about COVID-19 Lockdown among General Population, France, March 2020.
    Peretti-Watel P; Seror V; Cortaredona S; Launay O; Raude J; Verger P; Beck F; Legleye S; L'Haridon O; Ward J; ; Longitudinale E; ;
    Emerg Infect Dis; 2021 Jan; 27(1):301-3. PubMed ID: 33183493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Outpatient Attendance During COVID-19 Lockdown When Patients Were Given the Option to Return.
    Li WS; Heng DL; Chia TH; Lim EC; Tan EK
    Mov Disord; 2020 Dec; 35(12):2137-2138. PubMed ID: 33034901
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 control in Vietnam.
    Van Tan L
    Nat Immunol; 2021 Mar; 22(3):261. PubMed ID: 33627879
    [No Abstract]   [Full Text] [Related]  

  • 24. A "No More Waves" strategy for COVID-19 in Canada.
    Morris AM; Mintz JM
    CMAJ; 2021 Jan; 193(4):E132-E134. PubMed ID: 33298403
    [No Abstract]   [Full Text] [Related]  

  • 25. Flattening the Curve on COVID-19: South Korea's Measures in Tackling Initial Outbreak of Coronavirus.
    Lee D; Heo K; Seo Y; Ahn H; Jung K; Lee S; Choi H
    Am J Epidemiol; 2021 Apr; 190(4):496-505. PubMed ID: 33106843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation thresholds for curbing SARS-CoV-2 resurgence.
    Yakob L
    Epidemiol Infect; 2021 Jul; 149():e168. PubMed ID: 34289920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of national and local lockdowns on the control of COVID-19 pandemic: a rapid review.
    Caristia S; Ferranti M; Skrami E; Raffetti E; Pierannunzio D; Palladino R; Carle F; Saracci R; Badaloni C; Barone-Adesi F; Belleudi V; Ancona C;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):60-68. PubMed ID: 33412795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digital herd immunity and COVID-19.
    Bulchandani VB; Shivam S; Moudgalya S; Sondhi SL
    Phys Biol; 2021 Jun; 18(4):. PubMed ID: 33827059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Panacea for Australia's COVID-19 Crisis? Weighing Some Legal Implications of Mandatory Vaccination.
    Wolf G; Taliadoros J; Gleeson P
    J Law Med; 2021 Dec; 28(4):993-1017. PubMed ID: 34907682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Universal masking is an effective strategy to flatten the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) healthcare worker epidemiologic curve.
    Seidelman JL; Lewis SS; Advani SD; Akinboyo IC; Epling C; Case M; Said K; Yancey W; Stiegel M; Schwartz A; Stout J; Sexton DJ; Smith BA
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1466-1467. PubMed ID: 32576336
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19 on the Nile: Review on the Management and Outcomes of the COVID-19 Pandemic in the Arab Republic of Egypt from February to August 2020.
    Gaye YE; Agbajogu C; El Oakley R
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Insights from Australia's 'second wave' (COVED-4).
    O'Reilly GM; Mitchell RD; Mitra B; Akhlaghi H; Tran V; Furyk JS; Buntine P; Wong A; Gangathimmaiah V; Knott J; Raos M; Chatterton E; Sevior C; Parker S; Baker S; Loughman A; Lowry N; Freeman D; Sri-Ganeshan M; Chapman N; Siu S; Noonan MP; Smit V; Cameron PA;
    Emerg Med Australas; 2021 Apr; 33(2):331-342. PubMed ID: 33315310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 Down Under: Australia's Initial Pandemic Experience.
    Cook MJ; Dri GG; Logan P; Tan JB; Flahault A
    Int J Environ Res Public Health; 2020 Dec; 17(23):. PubMed ID: 33271867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early evidence of effectiveness of digital contact tracing for SARS-CoV-2 in Switzerland.
    Salathé M; Althaus C; Anderegg N; Antonioli D; Ballouz T; Bugnon E; Čapkun S; Jackson D; Kim SI; Larus J; Low N; Lueks W; Menges D; Moullet C; Payer M; Riou J; Stadler T; Troncoso C; Vayena E; von Wyl V
    Swiss Med Wkly; 2020 Dec; 150():w20457. PubMed ID: 33327003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of sustaining non-pharmaceutical interventions for COVID-19 until herd immunity.
    Huang J; Xu W; Zheng Z; Wong MCS
    Hong Kong Med J; 2021 Apr; 27(2):95-96. PubMed ID: 33879626
    [No Abstract]   [Full Text] [Related]  

  • 38. Test and trace strategy has overlooked importance of clinical input, clinical oversight and integration.
    Harding-Edgar L; McCartney M; Pollock AM
    J R Soc Med; 2020 Nov; 113(11):428-432. PubMed ID: 33108948
    [No Abstract]   [Full Text] [Related]  

  • 39. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis.
    Berardis S; Verroken A; Vetillart A; Struyf C; Gilbert M; Gruson D; Gohy S
    J Cyst Fibros; 2020 Nov; 19(6):872-874. PubMed ID: 32828701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    De Foo C; Grépin KA; Cook AR; Hsu LY; Bartos M; Singh S; Asgari N; Teo YY; Heymann DL; Legido-Quigley H
    Lancet; 2021 Oct; 398(10311):1547-1551. PubMed ID: 34619099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.